WASHINGTON — The Trump administration has opened another front in its overhaul of U.S. vaccine policy, with the Department of Health and Human Services (HHS) asking the public to weigh in on how childhood vaccines should be recommended, categorized and administered.
The request for public feedback, announced Friday, August 21, comes less than two weeks after President Donald Trump signed an executive order calling for a narrower set of federal childhood vaccine recommendations and a review of when and how children receive their shots.
But there is an important distinction: HHS has not announced a new vaccine schedule through this latest notice. Instead, the department is asking parents, doctors, health officials and other members of the public to comment on possible changes to the federal recommendation framework.
The public has until September 20, 2026, to submit comments.
HHS Considers New Categories for Childhood Vaccines
Under the current framework, vaccines can be recommended routinely for everyone, recommended for particular risk groups, or placed under a shared clinical decision-making category in which patients and healthcare providers discuss whether vaccination is appropriate.
The new HHS request asks whether additional categories should be created.
Among the possibilities being considered are recommendations for vaccines that would be given outside infancy or vaccines that would remain recommended but only under certain qualifications. The department is also asking for feedback on whether childhood vaccinations should be administered across broader age windows or at separate medical visits.
HHS is also examining the shared-decision-making model itself, including whether it could create confusion for parents and physicians, reduce vaccination rates or place additional demands on healthcare providers.
That makes the latest announcement more than a routine request for comments. It provides a glimpse into how the administration could reshape the way Americans receive federal vaccine guidance.
Trump’s 11-Vaccine Plan Is Already Reshaping the Debate
The latest HHS review follows Trump’s August 10 executive order, which established what the administration calls “Gold Standard Childhood Vaccine Recommendations.”
The order identifies 11 immunizations as recommended for all children: vaccines protecting against measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B, pneumococcal disease, HPV and varicella.
Other vaccines—including hepatitis A and B, rotavirus, meningococcal vaccines, influenza and COVID-19 vaccines—were placed into categories involving certain high-risk groups or shared clinical decision-making.
The order also calls for the administration of the measles, mumps and rubella vaccine as three separate shots once individual products become available domestically. It further directs federal officials to study the timing and sequencing of childhood vaccinations and explore administering vaccines at separate medical visits.
The White House says the approach is intended to align U.S. recommendations with what it describes as scientific evidence and practices in other developed countries.
Why Doctors and Public Health Experts Are Watching Closely
The policy debate is unfolding as U.S. childhood vaccination coverage has already been slipping.
According to newly released federal data reported by The Associated Press, the percentage of U.S. kindergarteners exempted from one or more vaccine requirements reached 4.2% during the 2025-2026 school year, up from 3.6% the previous year. That represents an estimated 155,000 children nationwide, with exemptions increasing in 41 states and Washington, D.C.
The national vaccination rate for the measles, mumps and rubella vaccine fell to 92.4%, compared with roughly 95% before the COVID-19 pandemic. Rates for polio, DTaP and chickenpox vaccination also declined.
Public health experts have warned that falling vaccination coverage can leave larger pockets of children susceptible to diseases that vaccines are designed to prevent.
The timing has added urgency because the United States is also experiencing a major measles problem. AP reported that the latest numbers indicate more than a quarter-million children entering kindergarten may be susceptible to measles.
The Kennedy Factor
The changes are closely associated with HHS Secretary Robert F. Kennedy Jr., whose long-standing vaccine skepticism has made him one of the most controversial figures in the administration’s health policy.
Reuters reported that the latest initiative advances Kennedy’s broader effort to reconsider federal vaccine recommendations, while noting that claims linking vaccines to autism have been repeatedly rejected by scientific research.
At the same time, the administration argues that the vaccine system needs greater transparency and public trust.
HHS said public confidence in federal health authorities declined during and after the COVID-19 pandemic and that concerns over previous recommendation processes contributed to doubts about the credibility of vaccine guidance. The department says the new feedback process is intended to help determine whether the existing framework adequately supports scientific rigor, informed choice and public trust.
A New CDC Director Adds Another Layer to the Story
The vaccine debate is also unfolding as the Centers for Disease Control and Prevention gets a new permanent director.
Dr. Erica Schwartz was confirmed by the Senate on August 5. During her confirmation process, Schwartz said she believes vaccines are safe and effective and described herself as willing to engage with parents who have concerns about vaccination.
Her arrival could become significant as federal health officials attempt to reconcile the administration’s push for a different vaccine policy with concerns over declining vaccination rates and public confidence.
What Happens Next?
For now, the newest HHS announcement does not mean that parents suddenly have a new federal vaccination schedule to follow.
Instead, the department is collecting public comments before considering possible changes to how recommendations are categorized, when vaccines are given and how federal guidance is communicated.
The September 20 deadline could therefore become an important milestone in the administration’s broader effort to reshape U.S. childhood vaccine policy.
The bigger question is what HHS will ultimately do with the feedback—and whether the next phase will bring additional changes to the vaccines recommended for American children.
For parents, physicians and public health officials, that decision could have consequences far beyond the wording of a federal guideline.
Leave a Reply